Role of the mesolimbic cholinergic projection to the septum in the production of 22 kHz alarm calls in rats.
The role of the ascending cholinergic projection from the laterodorsal tegmental nucleus (LDT) to septum in the production of 22 kHz ultrasonic vocalization was studied in adult rats, using behavioral-pharmacological and anatomical tracing methods. Direct application of carbachol, a muscarinic agonist, into the lateral septal region induced species-typical 22 kHz alarm calls. The septum receives cholinergic input from LDT, thus, activation with glutamate of predominantly cholinergic neurons of the LDT induced comparable 22 kHz alarm calls in the same animals. This glutamate-induced response from LDT was significantly reduced when the lateral septum was pretreated with scopolamine, a cholinergic antagonist. To investigate the localization of the cell groups projecting to septum, the fluorescent retrograde tracer, fluorogold, was pressure injected into the lateral septum and sections from these brains were also immunostained against choline acetyltransferase (ChAT) to visualize cholinergic cell bodies. Several ChAT-fluorogold double-labeled cells within the boundaries of the LDT were found, while other fluorogold-labeled regions did not contain double-labeled cells. These results provide both direct and indirect evidence that at least a part of the mesolimbic ascending cholinergic projection from LDT to septum is involved in the initiation of the 22 kHz vocalization. It is concluded that the septum is an integral part of the medial cholinoceptive vocalization strip and the 22 kHz alarm vocalization is triggered from septum by the cholinergic input from the LDT.
Bihari
Aurelia
A
Department of Anatomy and Cell Biology, University of Western Ontario, London, Ont., Canada N6A 5A5.
Hrycyshyn
A W
AW
Brudzynski
Stefan M
SM
D000162:Acoustics; D000344:Afferent Pathways / Q000187:drug effects / Q000502:physiology; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D002217:Carbachol / Q000494:pharmacology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D018679:Cholinergic Agonists / Q000494:pharmacology; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology*; D004347:Drug Interactions; D018698:Glutamic Acid / Q000494:pharmacology; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D018727:Muscarinic Antagonists / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011930:Reaction Time / Q000187:drug effects; D012601:Scopolamine / Q000494:pharmacology; D020665:Septum of Brain / Q000033:anatomy & histology / Q000502:physiology*; D013018:Sound Spectrography / Q000379:methods; D013238:Stereotaxic Techniques / Q000295:instrumentation; D013681:Tegmentum Mesencephali / Q000033:anatomy & histology / Q000187:drug effects / Q000502:physiology*; D014131:Trace Elements / Q000378:metabolism; D014828:Vocalization, Animal / Q000187:drug effects / Q000502:physiology*
D018679:Cholinergic Agonists; D018727:Muscarinic Antagonists; D014131:Trace Elements; D018698:Glutamic Acid; D002217:Carbachol; D012601:Scopolamine; D002795:Choline O-Acetyltransferase